tradingkey.logo

Nephros Inc

NEPH
View Detailed Chart

4.180USD

+0.120+2.96%
Close 09/19, 16:00ETQuotes delayed by 15 min
44.31MMarket Cap
33.39P/E TTM

Nephros Inc

4.180

+0.120+2.96%
Intraday
1m
30m
1h
D
W
M
D

Today

+2.96%

5 Days

-1.88%

1 Month

+1.21%

6 Months

+180.54%

Year to Date

+184.35%

1 Year

+131.58%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
59 / 167
Overall Ranking
179 / 4720
Industry
Professional & Commercial Services

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 2 analysts
Buy
Current Rating
5.500
Target Price
+35.47%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. It operates through the Water Filtration segment. In the medical markets, it sells water filtration products. In the commercial markets, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. Its products are marketed primarily to the food service, hospitality, convenience store, and health care markets. These commercial products are also marketed into medical markets, as supplemental filtration to its medical filters. The Company’s filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 41.97% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 14.16M.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD 74.00K.%!(EXTRA int=2)
Overvalued
The company’s latest PE is 33.27, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 5.84M shares, decreasing 3.04% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 323.44K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.63.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Nephros, Inc. is a water technology company providing filtration solutions to the medical and commercial markets. The Company provides water filtration products and services, along with water-quality education. It operates through the Water Filtration segment. In the medical markets, it sells water filtration products. In the commercial markets, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. Its products are marketed primarily to the food service, hospitality, convenience store, and health care markets. These commercial products are also marketed into medical markets, as supplemental filtration to its medical filters. The Company’s filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Ticker SymbolNEPH
CompanyNephros Inc
CEOMr. Robert Banks
Websitehttps://www.nephros.com/
KeyAI